Pre-Open Movers 09/08: (KURA) (ZUMZ) (CLDR) Higher; (TNTR) (AOBC) (EFX) Lower (more...)

September 8, 2017 9:05 AM

Today's After-Hours Movers

Kura Oncology, Inc., (Nasdaq: KURA) 34.3% HIGHER; announced positive topline results from a Phase 2 trial for its lead product candidate, tipifarnib, in patients with HRAS mutant relapsed or refractory squamous cell carcinomas of the head and neck (HNSCC). The Phase 2 trial achieved its primary endpoint prior to the completion of enrollment.

Tintri, Inc. (NASDAQ: TNTR) 23.7% LOWER; reported Q2 EPS of ($0.91), $0.02 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $34.9 million versus the consensus estimate of $35.68 million. Tintri, Inc. sees Q3 2018 EPS of ($0.81)-($0.77), versus the consensus of ($0.79). Tintri, Inc. sees Q3 2018 revenue of $36-37 million, versus the consensus of $42.82 million.

American Outdoor Brands (NASDAQ: AOBC) 17.2% LOWER; reported Q1 EPS of $0.02, $0.09 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $129 million versus the consensus estimate of $147.38 million. GUIDANCE: American Outdoor Brands sees Q2 2018 EPS of $0.07-$0.12, versus the consensus of $0.27. American Outdoor Brands sees Q2 2018 revenue of $140-150 million, versus the consensus of $171.4 million. American Outdoor Brands sees FY2018 EPS of $1.04-$1.24, versus the consensus of $1.54. American Outdoor Brands sees FY2018 revenue of $700-740 million, versus the consensus of $777.4 million

Equifax (NYSE: EFX) 13.5% LOWER; Shares Pressured Post-Market After Company Discloses Massive Breach of Data on 143 Million Consumers

Zumiez, Inc. (NASDAQ: ZUMZ) 13% HIGHER; reported Q2 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $192.2 million versus the consensus estimate of $192.12 million. Comparable sales for the thirteen weeks ended July 29, 2017 increased 4.7% compared to a comparable sales decrease of 4.9% for the thirteen weeks ended July 30, 2016. August 2017 Comparable Sales Increased 7.4% GUIDANCE: Zumiez, Inc. sees Q3 2017 EPS of $0.43-$0.48, versus the consensus of $0.43. Zumiez, Inc. sees Q3 2017 revenue of $236-241 million, versus the consensus of $228.21 million.

Finisar (NASDAQ: FNSR) 6.5% LOWER; reported Q1 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $341.8 million versus the consensus estimate of $341.24 million. GUIDANCE: Finisar sees Q2 2018 EPS of $0.27-$0.30, versus the consensus of $0.50. Finisar sees Q2 2018 revenue of $322-342 million vs $369.2 consensus.

Kroger (NYSE: KR) 6.3% LOWER; reported Q2 EPS of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $27.6 billion versus the consensus estimate of $27.49 billion. Kroger confirms 2017 net earnings guidance for 53 weeks of $1.74-$1.79 per diluted share. Kroger confirms adjusted net earnings guidance range of $2.00 to $2.05 per diluted share. The company\'s LIFO expectation remains unchanged at $80 million.

Cloudera, Inc. (NYSE: CLDR) 5.3% HIGHER; reported Q2 EPS of ($0.17), $0.08 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $89.8 million versus the consensus estimate of $85.46 million. GUIDANCE: Cloudera, Inc. sees Q3 2018 EPS of ($0.25)-($0.23), versus the consensus of ($0.27). Cloudera, Inc. sees Q3 2018 revenue of $90-92 million, versus the consensus of $88.3 million. Cloudera, Inc. sees FY2018 EPS of ($0.95)-($0.93), versus the consensus of ($1.05). Cloudera, Inc. sees FY2018 revenue of $355-360 million, versus the consensus of $347.91 million.

VeriFone Systems (NYSE: PAY) 5% LOWER; reported Q3 EPS of $0.36, in-line with the analyst estimate of $0.36. Revenue for the quarter came in at $467 million versus the consensus estimate of $464.23 million. GUIDANCE: VeriFone Systems sees Q4 2017 EPS of $0.43, versus the consensus of $0.46. VeriFone Systems sees Q4 2017 revenue of $470-473 million, versus the consensus of $474.7 million. VeriFone Systems sees FY2017 EPS of $1.30, versus the consensus of $1.33. VeriFone Systems sees FY2017 revenue of $1.864-1.867 billion, versus the consensus of $1.87 billion.

Science Applications Int'l (NYSE: SAIC) 4.9% LOWER; reported Q2 EPS of $0.80, $0.10 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.08 billion.

Sturm Ruger & Company (NYSE: RGR) 3.6% LOWER; down on AOBC numbers

Redfin (NASDAQ: RDFN) 3.6% HIGHER; reported Q2 EPS of $0.06 versus $0.06 reported last year. Revenue for the quarter came in at $104.9 million versus the consensus estimate of $104.78 million. Redfin sees Q3 2017 revenue of $108.5-110.5 million, versus the consensus of $107.05 million.

Okta, Inc. (NASDAQ: OKTA) 3.2% HIGHER; reported Q2 EPS of ($0.16), $0.10 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $61 million versus the consensus estimate of $55.9 million. GUIDANCE: Okta, Inc. sees Q3 2018 EPS of ($0.25)-($0.24), versus the consensus of ($0.29). Okta, Inc. sees Q3 2018 revenue of $62-63 million, versus the consensus of $60.3 million. Okta, Inc. sees FY 2018 EPS of ($0.0.98)-($0.95), versus the consensus of ($1.13). Okta, Inc. sees FY 2018 revenue of $243-245 million, versus the consensus of $235.9 million.

SunPower (NASDAQ: SPWR) 2.3% LOWER; Macquarie downgraded from Outperform to Neutral.

NewLink Genetics (NASDAQ: NLNK) 2% HIGHER; Jefferies upgraded from Hold to Buy with a price target of $26.00 (from $7.00).

Categories

Special Reports

Next Articles